Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1978 1
1982 1
1983 1
1984 4
1985 2
1986 1
1987 3
1988 6
1989 3
1990 2
1992 1
1993 2
1994 2
1995 1
1996 3
1997 1
1998 3
1999 2
2000 5
2001 4
2002 6
2003 9
2004 11
2005 5
2006 5
2007 10
2008 15
2009 19
2010 17
2011 19
2012 16
2013 13
2014 30
2015 38
2016 49
2017 40
2018 52
2019 65
2020 63
2021 83
2022 85
2023 91
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

733 results

Results by year

Filters applied: . Clear all
Page 1
The Obsessive-Compulsive Inventory: development and validation of a short version.
Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, Salkovskis PM. Foa EB, et al. Psychol Assess. 2002 Dec;14(4):485-96. Psychol Assess. 2002. PMID: 12501574
This article reports on the development of a revised version of the Obsessive-Compulsive Inventory (OCI; E. B. Foa, M. J. Kozak, P. Salkovskis, M. E. Coles, & N. Amir, 1998), a psychometrically sound, theoretically driven, self-report measure. ...
This article reports on the development of a revised version of the Obsessive-Compulsive Inventory (OCI; E. B. Foa, M. J. Kozak, P. S …
Resveratrol (RV): A pharmacological review and call for further research.
Zhang LX, Li CX, Kakar MU, Khan MS, Wu PF, Amir RM, Dai DF, Naveed M, Li QY, Saeed M, Shen JQ, Rajput SA, Li JH. Zhang LX, et al. Biomed Pharmacother. 2021 Nov;143:112164. doi: 10.1016/j.biopha.2021.112164. Epub 2021 Oct 2. Biomed Pharmacother. 2021. PMID: 34649335 Free article. Review.
The RV also shows significant antibacterial effects against various food-borne pathogens (Listeria, Campylobacter, Staphylococcus aureus, and E. coli) by inhibiting an electron transport chain (ETC) and F0F1-ATPase, which decreases the production of cellular energy that le …
The RV also shows significant antibacterial effects against various food-borne pathogens (Listeria, Campylobacter, Staphylococcus aureus, an …
Correction to Amir et al. (2023).
[No authors listed] [No authors listed] J Exp Psychol Gen. 2023 Oct;152(10):2896. doi: 10.1037/xge0001473. Epub 2023 Aug 10. J Exp Psychol Gen. 2023. PMID: 37561499
Reports an error in "Computational signatures of inequity aversion in children across seven societies" by Dorsa Amir, David Melnikoff, Felix Warneken, Peter R. Blake, John Corbit, Tara C. ...In the original article, there were affiliation errors for the first and 14(th) au …
Reports an error in "Computational signatures of inequity aversion in children across seven societies" by Dorsa Amir, David Melnikoff …
Author Reply.
Groutz A, Gold R, Gordon D, Azem F, Shimonov M, Amir H. Groutz A, et al. Urology. 2021 Mar;149:265-266. doi: 10.1016/j.urology.2021.01.002. Epub 2021 Jan 13. Urology. 2021. PMID: 33453197 No abstract available.
Long-Term Health Outcomes of Lecanemab in Patients with Early Alzheimer's Disease Using Simulation Modeling.
Tahami Monfared AA, Tafazzoli A, Ye W, Chavan A, Zhang Q. Tahami Monfared AA, et al. Neurol Ther. 2022 Jun;11(2):863-880. doi: 10.1007/s40120-022-00350-y. Epub 2022 Apr 25. Neurol Ther. 2022. PMID: 35469060 Free PMC article.
METHODS: A disease simulation model was used to predict the long-term clinical outcomes of lecanemab for patients with early AD [i.e., mild cognitive impairment (MCI) due to AD and mild AD dementia] on the basis of BAN2401-G000-201 trial data and published literature. ...
METHODS: A disease simulation model was used to predict the long-term clinical outcomes of lecanemab for patients with early AD [i.e. …
The enmity paradox.
Ghasemian A, Christakis NA. Ghasemian A, et al. Sci Rep. 2023 Nov 16;13(1):20040. doi: 10.1038/s41598-023-47167-9. Sci Rep. 2023. PMID: 37973933 Free PMC article.
We also confirm the "generalized" enmity paradox for non-topological attributes in real data, analogous to the generalized friendship paradox (e.g., the claim that a person's enemies are richer, on average, than a person is). ...
We also confirm the "generalized" enmity paradox for non-topological attributes in real data, analogous to the generalized friendship parado …
A Path to Improved Alzheimer's Care: Simulating Long-Term Health Outcomes of Lecanemab in Early Alzheimer's Disease from the CLARITY AD Trial.
Tahami Monfared AA, Ye W, Sardesai A, Folse H, Chavan A, Aruffo E, Zhang Q. Tahami Monfared AA, et al. Neurol Ther. 2023 Jun;12(3):863-881. doi: 10.1007/s40120-023-00473-w. Epub 2023 Apr 2. Neurol Ther. 2023. PMID: 37009976 Free PMC article.
Lecanemab is a humanized IgG1 monoclonal antibody targeting amyloid protofibrils for the treatment of early AD [i.e., mild cognitive impairment (MCI) or mild AD dementia]. In a recent 18-month phase III trial, using a double-blind, placebo-controlled design, lecanemab trea …
Lecanemab is a humanized IgG1 monoclonal antibody targeting amyloid protofibrils for the treatment of early AD [i.e., mild cognitive …
Neurodegeneration and the Circadian Clock.
Hood S, Amir S. Hood S, et al. Front Aging Neurosci. 2017 May 30;9:170. doi: 10.3389/fnagi.2017.00170. eCollection 2017. Front Aging Neurosci. 2017. PMID: 28611660 Free PMC article. Review.
Despite varied etiologies and symptoms, several neurodegenerative diseases-specifically, Alzheimer's (AD), Parkinson's (PD), and Huntington's diseases (HDs)-share the common feature of abnormal circadian rhythms, such as those in behavior (e.g., disrupted sleep/wake cycles …
Despite varied etiologies and symptoms, several neurodegenerative diseases-specifically, Alzheimer's (AD), Parkinson's (PD), and Huntington' …
The amidase regulatory gene (amiR) of Pseudomonas aeruginosa.
Cousens DJ, Clarke PH, Drew R. Cousens DJ, et al. J Gen Microbiol. 1987 Aug;133(8):2041-52. doi: 10.1099/00221287-133-8-2041. J Gen Microbiol. 1987. PMID: 3127537
Deletion of DNA sequences between the two genes resulted in increased synthesis of amidase in both E. coli and P. aeruginosa. The intervening sequences showed no repressing effect when tested in trans. The results suggested that the amiR gene could be transcribed fr …
Deletion of DNA sequences between the two genes resulted in increased synthesis of amidase in both E. coli and P. aeruginosa. The int …
E- and Z-trisubstituted macrocyclic alkenes for natural product synthesis and skeletal editing.
Mu Y, Hartrampf FWW, Yu EC, Lounsbury KE, Schrock RR, Romiti F, Hoveyda AH. Mu Y, et al. Nat Chem. 2022 Jun;14(6):640-649. doi: 10.1038/s41557-022-00935-y. Epub 2022 May 16. Nat Chem. 2022. PMID: 35577918 Free PMC article.
The first is the near-complete reversal of substrate-controlled selectivity in the formation of a macrolactam related to an antifungal natural product. The other is a late-stage stereoselective generation of an E-trisubstituted alkene in a 24-membered ring, en route to the …
The first is the near-complete reversal of substrate-controlled selectivity in the formation of a macrolactam related to an antifungal natur …
733 results